IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

GIANELLI, UMBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 15.077
NA - Nord America 12.500
AS - Asia 11.761
Continente sconosciuto - Info sul continente non disponibili 1.654
SA - Sud America 972
AF - Africa 240
OC - Oceania 55
Totale 42.259
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.944
GB - Regno Unito 4.173
CN - Cina 3.907
DE - Germania 3.507
SG - Singapore 3.177
IT - Italia 3.039
BD - Bangladesh 1.199
RU - Federazione Russa 1.026
HK - Hong Kong 941
SE - Svezia 883
VN - Vietnam 768
BR - Brasile 700
IN - India 519
FR - Francia 513
NL - Olanda 384
CA - Canada 375
IE - Irlanda 313
TR - Turchia 308
UA - Ucraina 299
FI - Finlandia 292
KR - Corea 285
JP - Giappone 152
ID - Indonesia 149
EU - Europa 107
CI - Costa d'Avorio 88
PL - Polonia 86
CO - Colombia 85
DK - Danimarca 83
AR - Argentina 82
BE - Belgio 80
ES - Italia 77
GR - Grecia 69
MX - Messico 67
AU - Australia 50
CH - Svizzera 42
IQ - Iraq 41
AT - Austria 38
PH - Filippine 35
PK - Pakistan 35
ZA - Sudafrica 30
EC - Ecuador 29
UZ - Uzbekistan 29
SA - Arabia Saudita 27
VE - Venezuela 26
MA - Marocco 23
RO - Romania 23
CZ - Repubblica Ceca 21
EG - Egitto 21
MY - Malesia 20
AE - Emirati Arabi Uniti 19
CR - Costa Rica 19
PT - Portogallo 18
JM - Giamaica 17
JO - Giordania 16
TH - Thailandia 16
LT - Lituania 15
PE - Perù 15
CL - Cile 14
IR - Iran 14
KE - Kenya 13
NO - Norvegia 13
NP - Nepal 13
PY - Paraguay 12
TW - Taiwan 12
AL - Albania 11
GT - Guatemala 11
HU - Ungheria 11
IL - Israele 11
TN - Tunisia 11
TT - Trinidad e Tobago 11
DZ - Algeria 10
KZ - Kazakistan 9
LU - Lussemburgo 8
PA - Panama 8
RS - Serbia 8
DO - Repubblica Dominicana 7
ET - Etiopia 7
LB - Libano 7
SI - Slovenia 7
SK - Slovacchia (Repubblica Slovacca) 7
SN - Senegal 7
HN - Honduras 6
PS - Palestinian Territory 6
AM - Armenia 5
AZ - Azerbaigian 5
BG - Bulgaria 5
BT - Bhutan 5
BY - Bielorussia 5
KG - Kirghizistan 5
MD - Moldavia 5
NI - Nicaragua 5
NZ - Nuova Zelanda 5
PR - Porto Rico 5
SC - Seychelles 5
SV - El Salvador 5
BO - Bolivia 4
BS - Bahamas 4
KH - Cambogia 4
LK - Sri Lanka 4
LV - Lettonia 4
Totale 40.636
Salva come PNG Salva come JPEG
Città #
Southend 3.853
Frankfurt am Main 2.489
Singapore 1.828
Ashburn 1.376
Chandler 873
Hong Kong 853
Milan 837
Dallas 788
Beijing 736
San Jose 720
Seattle 465
Ann Arbor 461
Santa Clara 419
Council Bluffs 372
Princeton 364
Los Angeles 340
Wilmington 334
New York 324
Dublin 311
Fairfield 263
Hanover 256
Ho Chi Minh City 252
Dearborn 215
Toronto 211
Jacksonville 210
Bengaluru 208
Lauterbourg 198
Woodbridge 198
Hefei 193
Rome 185
Hanoi 184
Nanjing 173
Guangzhou 172
Buffalo 169
Hangzhou 162
Boardman 150
Houston 147
Redmond 139
Helsinki 135
Moscow 135
Des Moines 128
Shanghai 120
Mountain View 116
Cambridge 115
Jakarta 97
Tianjin 95
Andover 91
Cangzhou 89
Abidjan 88
The Dalles 88
Munich 84
Phoenix 84
Sakarya 83
Naples 82
Seoul 77
Tokyo 71
Jinan 70
Brussels 69
São Paulo 67
Serra 65
Columbus 62
Warsaw 62
Istanbul 61
Bogotá 60
Florence 60
Shenyang 60
Somerville 60
Changsha 56
Athens 54
Berlin 54
Chicago 53
Nanchang 53
Turin 53
Atlanta 46
Bologna 45
Redwood City 45
Fuzhou 44
San Diego 43
Shenzhen 43
Zhengzhou 40
London 39
Chengdu 37
Washington 36
Mumbai 35
Haiphong 34
Hebei 34
Ilion 34
Grafing 33
Nuremberg 33
Palermo 33
Eitensheim 32
Montreal 32
Brooklyn 30
Jiaxing 30
Saint Petersburg 29
Baltimore 28
Margão 27
Verona 27
Bitonto 26
Da Nang 26
Totale 25.166
Salva come PNG Salva come JPEG
Nome #
Applicazione ai Tissue Microarray delle tecniche di immunoistochimica e di Ibridazione In Situ Fluorescente per la caratterizzazione immunofenotipica e citogenetica di linfoma a grandi cellule B diffuso 575
Low-dose subcutaneous alemtuzumab in refractory chronic lymphocytic leukaemia (CLL) : results of a prospective, single-arm multicentre study 412
International Consensus Classification of myeloid and lymphoid neoplasms: myeloproliferative neoplasms 392
Myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase fusion genes: A workshop report with focus on novel entities and a literature review including paediatric cases 381
Uncontrolled IL-17 Production by Intraepithelial Lymphocytes in a Case of non-IPEX Autoimmune Enteropathy 377
Variations in clinical presentation, frequency of hemophagocytosis and clinical behavior of intravascular lymphoma diagnosed in different geographical regions 373
Prognostic significance of a comprehensive histologic evaluation of reticulin fibrosis, collagen deposition and osteosclerosis in primary myelofibrosis patients. 372
Triple-Negative Essential Thrombocythemia: Clinical-Pathological and Molecular Features. A Single-Center Cohort Study 367
Inflammatory Pseudotumor of the Liver or Intrahepatic Cholangiocarcinoma, That's the Question: A Review of the Literature 339
Thrombopoietin/TGF-β1 Loop Regulates Megakaryocyte Extracellular Matrix Component Synthesis 330
Identification of kitM541l somatic mutation in chronic eosinophilic leukemia, not otherwise specified and its implication in low-dose imatinib response 326
Expression of endothelial protein C receptor and thrombomodulin in the intestinal tissue of patients with inflammatory bowel disease 325
Minimal morphological criteria for defining bone marrow dysplasia : a basis for clinical implementation of WHO classification of myelodysplastic syndromes 316
Mitochondrial fission factor is a novel Myc-dependent regulator of mitochondrial permeability in cancer 316
BCL-6 gene mutations in primary cutaneous B-cell lymphomas 314
Prognostic implications of the European consensus for grading of bone marrow fibrosis in chronic idiopathic myelofibrosis 310
Aggressive natural killer cell leukaemia with a complex karyotype : a case report 309
Integrating clinical, morphological, and molecular data to assess prognosis in patients with primary myelofibrosis at diagnosis : a practical approach 308
Apoptosis taqman low-density array : analysis of programmed cell death patway in CLL 300
Cytogenetic study in primary myelofibrosis at diagnosis: Clinical and histological association and impact on survival according to WHO 2017 classification in an Italian multicenter series 294
Prognostic implications of the european consensus for grading of bone marrow fibrosis in chronic idiopathic myelofibrosis 293
Clonal reticulohistiocytosis of the skin and bone marrow associated with systemic mastocytosis and acute myeloid leukaemia 292
Oxidative stress is increased in primary and post-polycythemia vera myelofibrosis 288
Biological and molecular characterization of a rare case of cutaneous Richter syndrome 285
In vivo imaging of lymph node migration of MNP- and (111) in-labeled dendritic cells in a transgenic mouse model of breast cancer (MMTV-Ras) 282
Disease progression in myeloproliferative neoplasms: comparing patients in accelerated phase with those in chronic phase with Increased blasts (<10%) or with other types of disease progression 282
Clinical and molecular characteristics of lymphoplasmacytic lymphoma not associated with an IgM monoclonal protein: A multicentric study of the Rete Ematologica Lombarda (REL) network 279
High levels of vascular endothelial growth factor protein expression are associated with an increased risk of transfusion dependence in myelodysplastic syndromes 278
ZAP-70 immunoreactivity is a prognostic marker of disease progression in chronic lymphocytic leukemia 275
Gene expression signature of the apoptotic patway in indolent CLL by low-density array technology 274
Comments on pre-fibrotic myelofibrosis and how should it be managed 274
Multifactorial neutropenia in a patient with acute promyelocytic leukemia and associated large granular lymphocyte expansion: A case report 272
Exogenous lipoid pneumonia secondary to repetitive micro-aspiration of paraffin oils laxatives 265
Diagnostic Role of Flow Cytometry Analysis of Bioptical Samples in the Diagnosis of Lymphoid Tumors 265
Magnetic Resonance Imaging of Stem Cell Transplantation in Injured Mouse Spinal Cord 264
Bcl-6 gene mutations in primary cutaneous B-cell lymphomas 260
PDGFB hypomethylation is a favourable prognostic biomarker in primary myelofibrosis 259
Endothelial precursors and mature endothelial cells are increased in the peripheral blood of myelodysplastic syndromes 257
An unusual type of myeloid sarcoma localization following myelofibrosis : a case report and literature review 257
Defective vasculogenesis in Systemic Sclerosis is related to apoptotic phenotype in bone marrow endothelial progenitors 256
Chronic idiopathic myelofibrosis complicated by pulmonary arterial hypertension is distinctively characterized by endothelial progenitor cell insufficiency and increased angiogenesis 255
Transcriptional analysis distinguishes breast implant-associated anaplastic large cell lymphoma from other peripheral T-cell lymphomas 255
Low dose campath 1-H is highly effective and safe in advanced chronic CLL 254
Assessment of selective homing and contribution to vessel formation of cryopreserved peripherally injected bone marrow mononuclear cells following experimental myocardial damage 254
Survivin expression in "low-risk" and "high-risk" myelodysplastic syndromes 253
Acute myeloid leukemia and pregnancy: Clinical experience from a single center and a review of the literature 251
The prevalence and clinical implications of c-kit expression in plasma cell myeloma 246
MRI evaluation of dendritic cell vaccination protocol in a murine model of breast cancer (MMTV-hRas) 245
Identification of imaging biomarkers for the assessment of tumour response to different treatments in a preclinical glioma model 243
Early detection of pulmonary hypertension in primary myelofibrosis: The role of echocardiography, cardiopulmonary exercise testing, and biomarkers 238
Comprehensive Biological and Molecular Characterization of a RARE Case of Cutaneous Richter Syndrome 238
Direct visualization of neo-vessel formation following peripheral injection of bone marrow derived CD34+ cells in experimental myocardial damage 236
Role of JAK2 mutation in the diagnosis of chronic myeloproliferative disorders in splanchnic vein thrombosis 236
The significance of bone marrow biopsy and JAK2V617F mutation in the differential diagnosis between the "early" prepolycythemic phase of polycythemia vera and essential thrombocythemia 236
Validation of an engineered cell model for in vitro and in vivo HIF-1α evaluation by different imaging modalities 236
Decitabine treatment for an unusual case of atypical chronic myeloid leukemia (aCML) with a concomitant chronic lymphocytic leukemia (CLL) 236
Multimodal hypoxia imaging in a preclinical glioma model 235
Discrepancies between bone marrow histopathology and clinical phenotype in BCR-ABL1-negative myeloproliferative neoplasms associated with splanchnic vein thrombosis 234
Clinical features of type 1 and 2 refractory celiac disease: Results from a large cohort over a decade 233
The translocation of marrow MNCs after experimental myocardial cryoinjury is proportional to the infarcted area 232
High-phosphate Causes Endothelial Extracellular Matrix Calcification by Inducing Endothelial Cell Mesenchymal Transition and Osteoblastic Differentiation 230
Biomarker testing implementation for molecularly targeted therapy in non-small cell lung cancer patients 230
Transient elastography spleen stiffness measurements in primary myelofibrosis patients: a pilot study in a single centre 230
Marked eosinophilia as initial presentation of breast implant-associated anaplastic large cell lymphoma 230
CD18 promoter methylation is associated with a higher risk of thrombotic complications in primary myelofibrosis 230
Indeterminate cell histiocytosis in association with later occurrence of acute myeloblastic leukaemia 228
Trapianto autologo di cellule mononucleate di derivazione midollare nell’infarto miocardico sperimentale. 228
Defective interaction of mutant calreticulin and SOCE in megakaryocytes from patients with myeloproliferative neoplasms 227
Proteomic screening identifies PF4/Cxcl4 as a critical driver of myelofibrosis 224
Vascular endothelial growth factor receptor-1 (VEGFR-1) expression is increased in Ph-chronic myeloproliferative disorders and correlates with the microvessel density and VEGF 224
VEGF expression correlates with microvessel density in Philadelphia chromosome-negative chronic myeloproliferative disorders 223
Iron regulatory proteins 1 and 2 in human monocytes, macrophages and duodenum : expression and regulation in hereditary hemochromatosis and iron deficiency 222
Immunohistochemical expression of vascular endothelial growth factor correlates with microvessel density in Ph- chronic myeloproliferative disorders 221
Essential thrombocythemia or chronic idiopathic myelofibrosis? A single-center study based on hematopoietic bone marrow histology 220
Impact on thrombotic risk of canonical and atypical CALR mutations in essential thrombocythemia. A single-center cohort study 220
Mediastinal lymphadenopathies and skin lesions in a 49-year-old Sinhalese man 218
Low-dose subcutaneous campath (CAM) is highly effective and safe in advanced and chemotherapy-refractory B-CLL : results of a prospectic and multicenter phase II study 217
Linfoma cutaneo a cellule B della zona marginale 217
CD146(+) bone marrow osteoprogenitors increase in the advanced stages of primary myelofibrosis 215
European Bone Marrow working group trial on reproducibility of World health organization criteria to discriminate essential thrombocythemia from prefibrotic primary myelofibrosis. Haematologica 2012;97(3):360-5 - Comment 215
Myelofibrosis and following chronic myeloid leukemia: imatinib and ruxolitinib treatment in two cases 215
TP53 Alterations Associate with Poor Response to Lenvatinib in Patients with Advanced Thyroid Cancer 214
Transcriptomic analysis in multiple myeloma and primary plasma cell leukemia with t(11;14) reveals different expression patterns with biological implications in venetoclax sensitivity 211
Primary soft tissue lymphomas: description of seven cases and review of the literature 208
Pathological and genomic features of myeloproliferative neoplasms associated with splanchnic vein thrombosis in a single-center cohort 206
MicroRNA as potential biomarker in HCV-associated diffuse large B-cell lymphoma 206
Erdheim-Chester Disease With Multiorgan Involvement, Following Polycythemia Vera : a Case Report 206
Successful treatment with Imatinib for systemic mastocytosis associated with MDS/MPN 203
Bone marrow localisation of metastatic melanoma and synchronous leukaemic evolution of low-risk myelodysplastic syndrome 202
Prognostic impact of bone marrow fibrosis and dyserythropoiesis in autoimmune hemolytic anemia 202
Is chronic neutropenia always a benign disease? Evidences from a 5-year prospective study 201
Clinical and Molecular Evidence for C-kit Receptor as a Therapeutic Target in Systemic Sclerosis (SSc) 199
Progressive splenomegaly and mild thrombocytosis in beta-thalassaemia trait and coexisting hereditary hemochromatosis: possible confounders for a subsequent hematological diagnosis 199
The molecular landscape of myeloproliferative neoplasms associated with splanchnic vein thrombosis: Current perspective 196
Clinical and prognostic implications of bone marrow fibrosis in chronic idiopathic myelofibrosis (CIMF) 195
Severe chronic diarrhea and maculopapular rash : a case report 194
Statins may increase the risk of liver dysfunction in patients treated with steroids for active graves' orbitopathy 193
Contribution of bone marrow derived cell angiogenesis in bcr/abl negative chronic myeloproliferative disease 193
Successful Imatinib Treatment for Systemic Mastocytosis Associated With Myelodysplastic/Myeloproliferative Neoplasm: Report of a Case and Literature Review 192
Myelodysplastic syndromes : microvascular density and immunohistochemical expression of the proteins controllin angiogenesis 191
Totale 25.834
Salva come PNG Salva come JPEG
Categoria #
all - tutte 109.705
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 109.705
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.442 0 162 304 149 164 134 198 146 357 240 140 448
2022/20232.907 370 292 287 325 349 541 61 173 277 45 116 71
2023/20243.544 64 143 102 135 433 196 422 411 206 405 500 527
2024/20256.084 439 726 358 685 356 232 212 517 304 529 506 1.220
2025/202613.713 1.225 856 1.391 1.114 1.058 844 1.428 672 1.343 944 1.528 1.310
2026/20271.237 1.014 223 0 0 0 0 0 0 0 0 0 0
Totale 42.259